|
1
|
Frühbeis C, Fröhlich D and Krämer-Albers
EM: Emerging roles of exosomes in neuron-glia communication. Front
Physiol. 3:1192012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frühbeis C, Fröhlich D, Kuo WP, Amphornrat
J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave
KA, et al: Neurotransmitter-triggered transfer of exosomes mediates
oligodendrocyte-neuron communication. PLoS Biol. 11:e10016042013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abels ER and Breakefield XO: Introduction
to extracellular vesicles: Biogenesis, RNA cargo selection,
content, release, and uptake. Cell Mol Neurobiol. 36:301–312. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Syn N, Wang L, Sethi G, Thiery JP and Goh
BC: Exosome-mediated metastasis: From epithelial-mesenchymal
transition to escape from immunosurveillance. Trends Pharmacol Sci.
37:606–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zaborowski MP, Balaj L, Breakefield XO and
Lai CP: Extracellular vesicles: Composition, biological relevance,
and methods of study. Bioscience. 65:783–797. 2015. View Article : Google Scholar
|
|
6
|
Grant R, Ansa-Addo E, Stratton D,
Antwi-Baffour S, Jorfi S, Kholia S, Krige L, Lange S and Inal J: A
filtration-based protocol to isolate human plasma membrane-derived
vesicles and exosomes from blood plasma. J Immunol Methods.
371:143–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Street JM, Barran PE, Mackay CL, Weidt S,
Balmforth C, Walsh TS, Chalmers RT, Webb DJ and Dear JW:
Identification and proteomic profiling of exosomes in human
cerebrospinal fluid. J Transl Med. 10:52012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pisitkun T, Shen RF and Knepper MA:
Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci USA. 101:13368–13373. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prado N, Marazuela EG, Segura E,
Fernández-García H, Villalba M, Théry C, Rodríguez R and Batanero
E: Exosomes from bronchoalveolar fluid of tolerized mice prevent
allergic reaction. J Immunol. 181:1519–1525. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Runz S, Keller S, Rupp C, Stoeck A, Issa
Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G and Altevogt P:
Malignant ascites-derived exosomes of ovarian carcinoma patients
contain CD24 and EpCAM. Gynecol Oncol. 107:563–571. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ogawa Y, Miura Y, Harazono A, Kanai-Azuma
M, Akimoto Y, Kawakami H, Yamaguchi T, Toda T, Endo T, Tsubuki M,
et al: Proteomic analysis of two types of exosomes in human whole
saliva. Biol Pharm Bull. 34:13–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aalberts M, van Dissel-Emiliani FM, van
Adrichem NP, van Wijnen M, Wauben MH, Stout TA and Stoorvogel W:
Identification of distinct populations of prostasomes that
differentially express prostate stem cell antigen, annexin A1, and
GLIPR2 in humans. Biol Reprod. 86:822012. View Article : Google Scholar
|
|
13
|
Andre F, Schartz NE, Movassagh M, Flament
C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier
T, et al: Malignant effusions and immunogenic tumour-derived
exosomes. Lancet. 360:295–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rak J and Guha A: Extracellular vesicles -
vehicles that spread cancer genes. BioEssays. 34:489–497. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khan S, Jutzy JM, Aspe JR, McGregor DW,
Neidigh JW and Wall NR: Survivin is released from cancer cells via
exosomes. Apoptosis. 16:1–12. 2011. View Article : Google Scholar :
|
|
16
|
Dutta S, Warshall C, Bandyopadhyay C,
Dutta D and Chandran B: Interactions between exosomes from breast
cancer cells and primary mammary epithelial cells leads to
generation of reactive oxygen species which induce DNA damage
response, stabilization of p53 and autophagy in epithelial cells.
PLoS One. 9:e975802014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roccaro AM, Sacco A, Maiso P, Azab AK, Tai
YT, Reagan M, Azab F, Flores LM, Campigotto F, Weller E, et al: BM
mesenchymal stromal cell-derived exosomes facilitate multiple
myeloma progression. J Clin Invest. 123:1542–1555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi S, Zhang Q, Xia Y, You B, Shan Y, Bao
L, Li L, You Y and Gu Z: Mesenchymal stem cell-derived exosomes
facilitate nasopharyngeal carcinoma progression. Am J Cancer Res.
6:459–472. 2016.PubMed/NCBI
|
|
20
|
Colombo M, Raposo G and Théry C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mathivanan S, Ji H and Simpson RJ:
Exosomes: Extracellular organelles important in intercellular
communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martins VR, Dias MS and Hainaut P:
Tumor-cell-derived microvesicles as carriers of molecular
information in cancer. Curr Opin Oncol. 25:66–75. 2013. View Article : Google Scholar
|
|
24
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taylor DD, Zacharias W and Gercel-Taylor
C: Exosome isolation for proteomic analyses and RNA profiling.
Methods Mol Biol. 728:235–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Momen-Heravi F, Balaj L, Alian S, Tigges
J, Toxavidis V, Ericsson M, Distel RJ, Ivanov AR, Skog J and Kuo
WP: Alternative methods for characterization of extracellular
vesicles. Front Physiol. 3:3542012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Nedawi K, Meehan B and Rak J:
Microvesicles: Messengers and mediators of tumor progression. Cell
Cycle. 8:2014–2018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ratajczak J, Wysoczynski M, Hayek F,
Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived
microvesicles: Important and underappreciated mediators of
cell-to-cell communication. Leukemia. 20:1487–1495. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Azmi AS, Bao B and Sarkar FH: Exosomes in
cancer development, metastasis, and drug resistance: A
comprehensive review. Cancer Metastasis Rev. 32:623–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu DD, Wu Y, Shen HY, Lv MM, Chen WX,
Zhang XH, Zhong SL, Tang JH and Zhao JH: Exosomes in development,
metastasis and drug resistance of breast cancer. Cancer Sci.
106:959–964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Robinson SM, Fan L, White SA, Charnley RM
and Mann J: The role of exosomes in the pathogenesis of pancreatic
ductal adenocarcinoma. Int J Biochem Cell Biol. 75:131–139. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med (Berl). 91:431–437. 2013. View Article : Google Scholar
|
|
33
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
35
|
Funasaka T and Raz A: The role of
autocrine motility factor in tumor and tumor microenvironment.
Cancer Metastasis Rev. 26:725–735. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Funasaka T and Wong RW: The role of
nuclear pore complex in tumor microenvironment and metastasis.
Cancer Metastasis Rev. 30:239–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoon YJ, Kim DK, Yoon CM, Park J, Kim YK,
Roh TY and Gho YS: Egr-1 activation by cancer-derived extracellular
vesicles promotes endothelial cell migration via ERK1/2 and JNK
signaling pathways. PLoS One. 9:e1151702014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X,
Shi L, Lu X, Xu W, Lu L, et al: STAT3-regulated exosomal miR-21
promotes angiogenesis and is involved in neoplastic processes of
transformed human bronchial epithelial cells. Cancer Lett.
370:125–135. 2016. View Article : Google Scholar
|
|
41
|
Zomer A, Maynard C, Verweij FJ, Kamermans
A, Schäfer R, Beerling E, Schiffelers RM, de Wit E, Berenguer J,
Ellenbroek SIJ, et al: In Vivo imaging reveals extracellular
vesicle-mediated phenocopying of metastatic behavior. Cell.
161:1046–1057. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fleury A, Martinez MC and Le Lay S:
Extracellular vesicles as therapeutic tools in cardiovascular
diseases. Front Immunol. 5:3702014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kosaka N: Decoding the secret of cancer by
means of extracellular vesicles. J Clin Med. 5:52016. View Article : Google Scholar
|
|
44
|
Kosaka N, Iguchi H, Hagiwara K, Yoshioka
Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2
(nSMase2)-dependent exosomal transfer of angiogenic microRNAs
regulate cancer cell metastasis. J Biol Chem. 288:10849–10859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
You B, Cao X, Shao X, Ni H, Shi S, Shan Y,
Gu Z and You Y: Clinical and biological significance of HAX-1
overexpression in nasopharyngeal carcinoma. Oncotarget.
7:12505–12524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Clayton A, Al-Taei S, Webber J, Mason MD
and Tabi Z: Cancer exosomes express CD39 and CD73, which suppress T
cells through adenosine production. J Immunol. 187:676–683. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wieckowski EU, Visus C, Szajnik M,
Szczepanski MJ, Storkus WJ and Whiteside TL: Tumor-derived
microvesicles promote regulatory T cell expansion and induce
apoptosis in tumor-reactive activated CD8+ T
lymphocytes. J Immunol. 183:3720–3730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Soki FN, Koh AJ, Jones JD, Kim YW, Dai J,
Keller ET, Pienta KJ, Atabai K, Roca H and McCauley LK:
Polarization of prostate cancer-associated macrophages is induced
by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J
Biol Chem. 289:24560–24572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Whitehead B, Wu L, Hvam ML, Aslan H, Dong
M, Dyrskjøt L, Ostenfeld MS, Moghimi SM and Howard KA: Tumour
exosomes display differential mechanical and complement activation
properties dependent on malignant state: Implications in
endothelial leakiness. J Extracell Vesicles. 4:296852015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu
Y and Feng J: Exosomes: Decreased sensitivity of lung cancer A549
cells to cisplatin. PLoS One. 9:e895342014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH,
Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, et al: Exosomes from
drug-resistant breast cancer cells transmit chemoresistance by a
horizontal transfer of microRNAs. PLoS One. 9:e952402014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhong S, Chen X, Wang D, Zhang X, Shen H,
Yang S, Lv M, Tang J and Zhao J: MicroRNA expression profiles of
drug-resistance breast cancer cells and their exosomes. Oncotarget.
7:19601–19609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu DD, Wu Y, Zhang XH, Lv MM, Chen WX,
Chen X, Yang SJ, Shen H, Zhong SL, Tang JH, et al: Exosomes from
adriamycin-resistant breast cancer cells transmit drug resistance
partly by delivering miR-222. Tumour Biol. 37:3227–3235. 2016.
View Article : Google Scholar
|
|
54
|
Corcoran C, Rani S, O'Brien K, O'Neill A,
Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, et
al: Docetaxel-resistance in prostate cancer: Evaluating associated
phenotypic changes and potential for resistance transfer via
exosomes. PLoS One. 7:e509992012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Brinton LT, Sloane HS, Kester M and Kelly
KA: Formation and role of exosomes in cancer. Cell Mol Life Sci.
72:659–671. 2015. View Article : Google Scholar
|
|
56
|
Yáñez-Mó M, Siljander PR, Andreu Z, Zavec
AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J,
et al: Biological properties of extracellular vesicles and their
physiological functions. J Extracell Vesicles. 4:270662015.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Silva M and Melo SA: Non-coding RNAs in
exosomes: New players in cancer biology. Curr Genomics. 16:295–303.
2015. View Article : Google Scholar
|
|
58
|
Guan M, Chen X, Ma Y, Tang L, Guan L, Ren
X, Yu B, Zhang W and Su B: MDA-9 and GRP78 as potential diagnostic
biomarkers for early detection of melanoma metastasis. Tumour Biol.
36:2973–2982. 2015. View Article : Google Scholar
|
|
59
|
Li J, Sherman-Baust CA, Tsai-Turton M,
Bristow RE, Roden RB and Morin PJ: Claudin-containing exosomes in
the peripheral circulation of women with ovarian cancer. BMC
Cancer. 9:2442009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fujita Y, Kuwano K, Ochiya T and Takeshita
F: The impact of extracellular vesicle-encapsulated circulating
microRNAs in lung cancer research. BioMed Res Int. 2014:4864132014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cazzoli R, Buttitta F, Di Nicola M,
Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived
from circulating exosomes as noninvasive biomarkers for screening
and diagnosing lung cancer. J Thorac Oncol. 8:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, et al:
Combined evaluation of a panel of protein and miRNA serum-exosome
biomarkers for pancreatic cancer diagnosis increases sensitivity
and specificity. Int J Cancer. 136:2616–2627. 2015. View Article : Google Scholar
|
|
63
|
Bryant RJ, Pawlowski T, Catto JW, Marsden
G, Vessella RL, Rhees B, Kuslich C, Visakorpi T and Hamdy FC:
Changes in circulating microRNA levels associated with prostate
cancer. Br J Cancer. 106:768–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Manterola L, Guruceaga E, Gállego
Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S,
Diez-Valle R, Segura V, Samprón N, Barrena C, et al: A small
noncoding RNA signature found in exosomes of GBM patient serum as a
diagnostic tool. Neuro Oncol. 16:520–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu J, Sun H, Wang X, Yu Q, Li S, Yu X and
Gong W: Increased exosomal microRNA-21 and microRNA-146a levels in
the cervicovaginal lavage specimens of patients with cervical
cancer. Int J Mol Sci. 15:758–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hiltbrunner S, Larssen P, Eldh M,
Martinez-Bravo MJ, Wagner AK, Karlsson MC and Gabrielsson S:
Exosomal cancer immunotherapy is independent of MHC molecules on
exosomes. Oncotarget. 7:38707–38717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rafi MA and Omidi Y: A prospective
highlight on exosomal nanoshuttles and cancer immunotherapy and
vaccination. Bioimpacts. 5:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang Y, Luo CL, He BC, Zhang JM, Cheng G
and Wu XH: Exosomes derived from IL-12-anchored renal cancer cells
increase induction of specific antitumor response in vitro: A novel
vaccine for renal cell carcinoma. Int J Oncol. 36:133–140.
2010.
|
|
70
|
Pashoutan Sarvar D, Shamsasenjan K and
Akbarzadehlaleh P: Mesenchymal stem cell-derived exosomes: New
opportunity in cell-free therapy. Adv Pharm Bull. 6:293–299. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lou G, Song X, Yang F, Wu S, Wang J, Chen
Z and Liu Y: Exosomes derived from miR-122-modified adipose
tissue-derived MSCs increase chemosensitivity of hepatocellular
carcinoma. J Hematol Oncol. 8:1222015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Shimbo K, Miyaki S, Ishitobi H, Kato Y,
Kubo T, Shimose S and Ochi M: Exosome-formed synthetic microRNA-143
is transferred to osteosarcoma cells and inhibits their migration.
Biochem Biophys Res Commun. 445:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Brennan B: Nasopharyngeal carcinoma.
Orphanet J Rare Dis. 1:232006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lee AW, Yau TK, Wong DH, Chan EW, Yeung
RM, Ng WT, Tong M, Soong IS and Sze WM: Treatment of stage IV(A-B)
nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy
and accelerated fractionation. Int J Radiat Oncol Biol Phys.
63:1331–1338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Strazzulla A, Barreca GS, Giancotti A,
Pisani V, Costa C, Zicca E, La Boria A, Roveda L, Liberto MC, Tucci
L, et al: Nasopharyngeal carcinoma: Review of the literature with a
focus on therapeutical implications. Infez Med. 23:224–229.
2015.PubMed/NCBI
|
|
76
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Sonnenschein C and Soto AM: The death of
the cancer cell. Cancer Res. 71:4334–4337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Robinson BD, Sica GL, Liu YF, Rohan TE,
Gertler FB, Condeelis JS and Jones JG: Tumor microenvironment of
metastasis in human breast carcinoma: A potential prognostic marker
linked to hematogenous dissemination. Clin Cancer Res.
15:2433–2441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Redon CE, Dickey JS, Nakamura AJ, Kareva
IG, Naf D, Nowsheen S, Kryston TB, Bonner WM, Georgakilas AG and
Sedelnikova OA: Tumors induce complex DNA damage in distant
proliferative tissues in vivo. Proc Natl Acad Sci USA.
107:17992–17997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Critchley-Thorne RJ, Simons DL, Yan N,
Miyahira AK, Dirbas FM, Johnson DL, Swetter SM, Carlson RW, Fisher
GA, Koong A, et al: Impaired interferon signaling is a common
immune defect in human cancer. Proc Natl Acad Sci USA.
106:9010–9015. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gourzones C, Barjon C and Busson P:
Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer
Biol. 22:127–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Salem HK and Thiemermann C: Mesenchymal
stromal cells: Current understanding and clinical status. Stem
Cells. 28:585–596. 2010.
|
|
83
|
Droujinine IA, Eckert MA and Zhao W: To
grab the stroma by the horns: From biology to cancer therapy with
mesenchymal stem cells. Oncotarget. 4:651–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kidd S, Spaeth E, Dembinski JL, Dietrich
M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M and Marini FC:
Direct evidence of mesenchymal stem cell tropism for tumor and
wounding microenvironments using in vivo bioluminescent imaging.
Stem Cells. 27:2614–2623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Vlassov AV, Magdaleno S, Setterquist R and
Conrad R: Exosomes: Current knowledge of their composition,
biological functions, and diagnostic and therapeutic potentials.
Biochim Biophys Acta. 1820:940–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Du T, Ju G, Wu S, Cheng Z, Cheng J, Zou X,
Zhang G, Miao S, Liu G and Zhu Y: Microvesicles derived from human
Wharton's jelly mesenchymal stem cells promote human renal cancer
cell growth and aggressiveness through induction of hepatocyte
growth factor. PLoS One. 9:e968362014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yeh SH, Liu RS, Wu LC, Yang DJ, Yen SH,
Chang CW, Yu TW, Chou KL and Chen KY: Fluorine-18
fluoromisonidazole tumour to muscle retention ratio for the
detection of hypoxia in nasopharyngeal carcinoma. Eur J Nucl Med.
23:1378–1383. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zheng YJ, Fan W, Zhao C, Yang XC, Cui NJ
and Chen FJ: Clinical application of 99mTc-HL91 hypoxia imaging in
nasopharyngeal carcinoma. Ai Zheng. 25:378–381. 2006.In Chinese.
PubMed/NCBI
|
|
89
|
Zheng YJ, Zhao C, Fan W, Liu H, Cui NJ and
Chen FJ: Changes of hypoxia in primary lesion of nasopharyngeal
carcinoma during the treatment course and the clinical value
thereof. Zhonghua Yi Xue Za Zhi. 87:2698–2702. 2007.In Chinese.
|
|
90
|
Hong B, Lui VWY, Hashiguchi M, Hui EP and
Chan ATC: Targeting tumor hypoxia in nasopharyngeal carcinoma. Head
Neck. 35:133–145. 2013. View Article : Google Scholar
|
|
91
|
Janssen HL, Haustermans KM, Balm AJ and
Begg AC: Hypoxia in head and neck cancer: How much, how important?
Head Neck. 27:622–638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yang Y, Yang X, Yang Y, Zhu H, Chen X,
Zhang H, Wang F, Qin Q, Cheng H and Sun X: Exosomes: A promising
factor involved in cancer hypoxic microenvironments. Curr Med Chem.
22:4189–4195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yang X, Zhu H, Ge Y, Liu J, Cai J, Qin Q,
Zhan L, Zhang C, Xu L, Liu Z, et al: Melittin enhances
radiosensitivity of hypoxic head and neck squamous cell carcinoma
by suppressing HIF-1α. Tumour Biol. 35:10443–10448. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Park JE, Tan HS, Datta A, Lai RC, Zhang H,
Meng W, Lim SK and Sze SK: Hypoxic tumor cell modulates its
microenvironment to enhance angiogenic and metastatic potential by
secretion of proteins and exosomes. Mol Cell Proteomics.
9:1085–1099. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Aga M, Bentz GL, Raffa S, Torrisi MR,
Kondo S, Wakisaka N, Yoshizaki T, Pagano JS and Shackelford J:
Exosomal HIF1α supports invasive potential of nasopharyngeal
carcinoma-associated LMP1-positive exosomes. Oncogene.
33:4613–4622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
You Y, Shan Y, Chen J, Yue H, You B, Shi
S, Li X and Cao X: Matrix metalloproteinase 13-containing exosomes
promote nasopharyngeal carcinoma metastasis. Cancer Sci.
106:1669–1677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ferradini L, Miescher S, Stoeck M, Busson
P, Barras C, Cerf-Bensussan N, Lipinski M, von Fliedner V and Tursz
T: Cytotoxic potential despite impaired activation pathways in T
lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer.
47:362–370. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS,
Zhang XS, Cui J, Zeng YX and Li J: Tumor-derived exosomes promote
tumor progression and T-cell dysfunction through the regulation of
enriched exosomal microRNAs in human nasopharyngeal carcinoma.
Oncotarget. 5:5439–5452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mrizak D, Martin N, Barjon C,
Jimenez-Pailhes AS, Mustapha R, Niki T, Guigay J, Pancré V, de
Launoit Y, Busson P, et al: Effect of nasopharyngeal
carcinoma-derived exosomes on human regulatory T cells. J Natl
Cancer Inst. 107:3632014.PubMed/NCBI
|
|
100
|
Simmen T: Hax-1: A regulator of calcium
signaling and apoptosis progression with multiple roles in human
disease. Expert Opin Ther Targets. 15:741–751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Fadeel B and Grzybowska E: HAX-1: A
multifunctional protein with emerging roles in human disease.
Biochim Biophys Acta. 1790:1139–1148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sharp TV, Wang HW, Koumi A, Hollyman D,
Endo Y, Ye H, Du MQ and Boshoff C: K15 protein of Kaposi's
sarcoma-associated herpesvirus is latently expressed and binds to
HAX-1, a protein with antiapoptotic function. J Virol. 76:802–816.
2002. View Article : Google Scholar
|
|
103
|
Lee AY, Lee Y, Park YK, Bae KH, Cho S, Lee
DH, Park BC, Kang S and Park SG: HS 1-associated protein X-1 is
cleaved by caspase-3 during apoptosis. Mol Cells. 25:86–90.
2008.PubMed/NCBI
|
|
104
|
Vafiadaki E, Arvanitis DA, Pagakis SN,
Papalouka V, Sanoudou D, Kontrogianni-Konstantopoulos A and Kranias
EG: The anti-apoptotic protein HAX-1 interacts with SERCA2 and
regulates its protein levels to promote cell survival. Mol Biol
Cell. 20:306–318. 2009. View Article : Google Scholar :
|
|
105
|
Al-Maghrebi M, Brulé H, Padkina M, Allen
C, Holmes WM and Zehner ZE: The 3′ untranslated region of human
vimentin mRNA interacts with protein complexes containing eEF-1
gamma and HAX-1. Nucleic Acids Res. 30:5017–5028. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Sarnowska E, Grzybowska EA, Sobczak K,
Konopinski R, Wilczynska A, Szwarc M, Sarnowski TJ, Krzyzosiak WJ
and Siedlecki JA: Hairpin structure within the 3′UTR of DNA
polymerase beta mRNA acts as a post-transcriptional regulatory
element and interacts with Hax-1. Nucleic Acids Res. 35:5499–5510.
2007. View Article : Google Scholar :
|
|
107
|
Ramsay AG, Keppler MD, Jazayeri M, Thomas
GJ, Parsons M, Violette S, Weinreb P, Hart IR and Marshall JF:
HS1-associated protein X-1 regulates carcinoma cell migration and
invasion via clathrin-mediated endocytosis of integrin alphavbeta6.
Cancer Res. 67:5275–5284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Radhika V, Onesime D, Ha JH and
Dhanasekaran N: Galpha13 stimulates cell migration through
cortactin-interacting protein Hax-1. J Biol Chem. 279:49406–49413.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Jiang Y, Zhang W, Kondo K, Klco JM, Martin
TB St, Dufault MR, Madden SL, Kaelin WG Jr and Nacht M: Gene
expression profiling in a renal cell carcinoma cell line:
Dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res.
1:453–462. 2003.PubMed/NCBI
|
|
111
|
Li M, Tang Y, Zang W, Xuan X, Wang N, Ma
Y, Wang Y, Dong Z and Zhao G: Analysis of HAX-1 gene expression in
esophageal squamous cell carcinoma. Diagn Pathol.
8:472013.PubMed/NCBI
|
|
112
|
Sun SJ, Feng L, Zhao GQ and Dong ZM: HAX-1
promotes the chemoresistance, invasion, and tumorigenicity of
esophageal squamous carcinoma cells. Dig Dis Sci. 57:1838–1846.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Wei XJ, Li SY, Yu B, Chen G, Du JF and Cai
HY: Expression of HAX-1 in human colorectal cancer and its clinical
significance. Tumour Biol. 35:1411–1415. 2014. View Article : Google Scholar
|
|
114
|
Li WB, Feng J, Geng SM, Zhang PY, Yan XN,
Hu G, Zhang CQ and Shi BJ: Induction of apoptosis by Hax-1 siRNA in
melanoma cells. Cell Biol Int. 33:548–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Banerjee A, Saito K, Meyer K, Banerjee S,
Ait-Goughoulte M, Ray RB and Ray R: Hepatitis C virus core protein
and cellular protein HAX-1 promote 5-fluorouracil-mediated
hepatocyte growth inhibition. J Virol. 83:9663–9671. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Janowska-Wieczorek A, Wysoczynski M,
Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J and
Ratajczak MZ: Microvesicles derived from activated platelets induce
metastasis and angiogenesis in lung cancer. Int J Cancer.
113:752–760. 2005. View Article : Google Scholar
|
|
117
|
Soldevilla B, Rodríguez M, San Millán C,
García V, Fernández-Periañez R, Gil-Calderón B, Martín P,
García-Grande A, Silva J, Bonilla F, et al: Tumor-derived exosomes
are enriched in ΔNp73, which promotes oncogenic potential in
acceptor cells and correlates with patient survival. Hum Mol Genet.
23:467–478. 2014. View Article : Google Scholar
|
|
118
|
Yu X, Wei F, Yu J, Zhao H, Jia L, Ye Y, Du
R, Ren X and Li H: Matrix metalloproteinase 13: A potential
intermediate between low expression of microRNA-125b and increasing
metastatic potential of non-small cell lung cancer. Cancer Genet.
208:76–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Hadler-Olsen E, Fadnes B, Sylte I,
Uhlin-Hansen L and Winberg JO: Regulation of matrix
metalloproteinase activity in health and disease. FEBS J.
278:28–45. 2011. View Article : Google Scholar
|
|
120
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hwang BM, Chae HS, Jeong YJ, Lee YR, Noh
EM, Youn HZ, Jung SH, Yu HN, Chung EY and Kim JS: Protein tyrosine
phosphatase controls breast cancer invasion through the expression
of matrix metalloproteinase-9. BMB Rep. 46:533–538. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Balbín M, Pendás AM, Uría JA, Jiménez MG,
Freije JP and López-Otín C: Expression and regulation of
collagenase-3 (MMP-13) in human malignant tumors. APMIS. 107:45–53.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Sedighi M, Aledavood SA, Abbaszadegan M,
Memar B, Montazer M, Rajabian M and Gholamin M: Matrix
metalloproteinase-13: A potential biomarker for detection and
prognostic assessment of patients with esophageal squamous Cell
Carcinoma. Asian Pac J Cancer Prev. 17:2781–2785. 2016.
|
|
124
|
Vairaktaris E, Yapijakis C, Nkenke E,
Serefoglou ZC, Chatzitheofylaktou A, Vassiliou S, Derka S,
Vylliotis A, Perrea D, Neukam FW, et al: A metalloproteinase-13
polymorphism affecting its gene expression is associated with
advanced stages of oral cancer. Anticancer Res. 27:4027–4030.
2007.
|
|
125
|
González-Arriaga P, López-Cima MF,
Fernández-Somoano A, Pascual T, Marrón MG, Puente XS and Tardón A:
Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung
cancer risk. BMC Cancer. 8:3782008. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li Y, Jia JH, Kang S, Zhang XJ, Zhao J,
Wang N, Zhou RM, Sun DL, Duan YN and Wang DJ: The functional
polymorphisms on promoter region of matrix metalloproteinase-12,
-13 genes may alter the risk of epithelial ovarian carcinoma in
Chinese. Int J Gynecol Cancer. 19:129–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Fan Y, Gan Y, Shen Y, Cai X, Song Y, Zhao
F, Yao M, Gu J and Tu H: Leptin signaling enhances cell invasion
and promotes the metastasis of human pancreatic cancer via
increasing MMP-13 production. Oncotarget. 6:16120–16134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
